tradingkey.logo
tradingkey.logo
Search

Zenas Biopharma Inc

ZBIO
Add to Watchlist
29.630USD
0.0000.00%
Close 09-23 16:00ET
1.87BMarket Cap
LossP/E TTM

ZBIO Financials

See Zenas Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.87B
Dividend TTM
0.00
P/E TTM
-3.25
EPS TTM
-9.10
Revenue
10.00M
Net Profit
-156.99M
ROE
-137.11%
ROA
-78.63%

Zenas Biopharma Inc Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
-1.77/-1.12
Revenue / Forecast
1.00M/18.75M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Financial Indicators
EPS
-41.57%-1.77
-81.28%-1.46
51.80%-4.53
-32.20%-1.22
-30.70%-1.25
-14.96%-0.80
-1420.62%-9.40
-203.26%-0.92
-30.74%-0.95
-45.57%-0.70
-29.45%-0.62
--0.89
---0.73
---0.48
---0.48
---2.52
Revenue
--1.00M
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--10.00M
--5.00M
-100.00%0.00
----
----
--0.00
--50.00M
----
----
--0.00
----
Net Profit
-113.42%-111.46M
-141.23%-80.99M
-357.08%-240.44M
-33.40%-51.50M
-37.51%-52.22M
-20.77%-33.57M
-113.95%-52.60M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.80M
-29.45%-24.59M
--35.61M
---29.05M
---19.10M
---18.99M
----
Net Margin
---11145.60%
----
----
----
----
---335.73%
---1052.08%
----
----
----
----
--71.21%
----
----
----
----
Gross Margin
--100.00%
----
----
----
----
--100.00%
--100.00%
----
----
----
----
--100.00%
----
----
----
----
Debt to assets ratio
--55.40%
--46.89%
--20.50%
--22.67%
----
----
-100.00%0.00%
-100.00%0.00%
--0.00%
--42.80%
--29.77%
--23.87%
----
----
----
----
Revenue
--1.00M
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--10.00M
--5.00M
-100.00%0.00
----
----
--0.00
--50.00M
----
----
--0.00
----
Operating profit
-40.78%-77.66M
-107.21%-77.35M
-28.21%-71.31M
-16.09%-47.58M
-38.94%-55.16M
-35.36%-37.33M
-124.48%-55.62M
-215.05%-40.98M
-110.01%-39.70M
-44.49%-27.58M
-30.49%-24.78M
--35.62M
---18.91M
---19.09M
---18.99M
----
Net Profit
-113.42%-111.46M
-141.23%-80.99M
-357.08%-240.44M
-33.40%-51.50M
-37.51%-52.22M
-20.77%-33.57M
-113.95%-52.60M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.80M
-29.45%-24.59M
--35.61M
---29.05M
---19.10M
---18.99M
----
Current assets
134.67%653.79M
129.75%730.16M
-1.34%351.17M
-24.67%296.64M
47.72%278.60M
700.42%317.81M
495.15%355.92M
413.56%393.78M
--188.60M
--39.70M
--59.80M
--76.68M
----
----
----
----
Total current liabilities
23.62%65.82M
24.48%61.16M
9.35%62.65M
19.15%52.42M
36.15%53.24M
61.98%49.13M
146.33%57.29M
182.81%44.00M
--39.11M
--30.33M
--23.26M
--15.56M
----
----
----
----
Total assets
139.42%701.69M
124.01%747.68M
3.70%383.64M
-20.18%322.02M
46.58%293.08M
580.45%333.77M
442.63%369.97M
381.47%403.43M
--199.95M
--49.05M
--68.18M
--83.79M
----
----
----
----
Total liabilities
750.36%454.59M
732.88%411.85M
146.04%141.50M
185.45%125.59M
36.65%53.46M
-3.91%49.45M
31.26%57.51M
22.42%44.00M
--39.12M
--51.46M
--43.81M
--35.94M
----
----
----
----
Total equity
3.12%247.10M
18.12%335.83M
-22.50%242.14M
-45.35%196.43M
48.99%239.63M
11902.28%284.32M
1182.41%312.46M
651.11%359.44M
--160.83M
---2.41M
--24.36M
--47.85M
----
----
----
----
Net operating income
-37.12%-57.24M
-102.95%-75.20M
-35.95%-52.41M
-32.41%-41.13M
-34.83%-41.74M
-93.96%-37.05M
-150.35%-38.55M
-197.53%-31.06M
-48.04%-30.96M
26.71%-19.10M
10.08%-15.40M
--31.85M
---20.91M
---26.06M
---17.13M
----
Net investment
-156.21%-287.70M
136.64%31.61M
-2399.71%-93.36M
249.64%40.04M
-320731.43%-112.29M
-392054.55%-86.27M
-21870.59%-3.73M
---26.76M
---35.00K
---22.00K
98.42%-17.00K
--0.00
--0.00
--0.00
---1.07M
----
Net financing
2342.33%42.06M
437757.58%433.48M
7500.81%140.84M
-68.96%72.62M
-99.03%1.72M
116.12%99.00K
3606.00%1.85M
1069.90%233.98M
1615709.09%177.74M
-1216.36%-614.00K
-99.92%50.00K
--20.00M
--11.00K
--55.00K
--59.39M
----

FAQs

What is the total revenue of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its total revenue reached 10.00M, with a year-on-year change of 5.00M.

What are the current assets of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its current assets were 351.17M, with a year-on-year change of -1.34.

What are the total assets of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its total assets of Zenas Biopharma Inc were 383.64M, with a year-on-year change of 3.70.

What are the total liabilities of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its total liabilities of Zenas Biopharma Inc were 141.50M, with a year-on-year change of 146.04.

What is the total equity of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its total equity of Zenas Biopharma Inc was 242.14M, with a year-on-year change of -22.50.

What is the net operating income of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its net operating income of Zenas Biopharma Inc was -211.38M, with a year-on-year change of -28.98.

What is the net investment of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its net investment of Zenas Biopharma Inc was -251.89M, with a year-on-year change of -724.45.

What is the net financing of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its net financing of Zenas Biopharma Inc was 215.28M, with a year-on-year change of -47.87.

What is the Earnings Per Share (EPS) of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.44, with a year-on-year change of 29.00.

What is the net income of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its net income was -377.74M, with a year-on-year change of -140.62.

What is the net margin of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its net profit margin was -3777.37, with a year-on-year change of -20.31.

What is the Return on Equity (ROE) of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -136.22, with a year-on-year change of 62.37.

What is the Return on Assets (ROA) of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -100.25, with a year-on-year change of -39.89.

What is the operating profit of Zenas Biopharma Inc?

According to Zenas Biopharma Inc's FY2025 earnings report, its operating profit was -211.38M, with a year-on-year change of -28.98.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.